Does STANOZOLOL Cause Left ventricular hypertrophy? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Left ventricular hypertrophy have been filed in association with STANOZOLOL. This represents 14.8% of all adverse event reports for STANOZOLOL.
26
Reports of Left ventricular hypertrophy with STANOZOLOL
14.8%
of all STANOZOLOL reports
13
Deaths
13
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From STANOZOLOL?
Of the 26 reports, 13 (50.0%) resulted in death, 13 (50.0%) required hospitalization, and 13 (50.0%) were considered life-threatening.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for STANOZOLOL. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does STANOZOLOL Cause?
Drug abuse (93)
Intentional product misuse (30)
Off label use (17)
Acute kidney injury (15)
Testicular atrophy (15)
Acute myocardial infarction (14)
Toxicity to various agents (14)
Hyperthyroidism (13)
Focal segmental glomerulosclerosis (12)
Drug-induced liver injury (11)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
TACROLIMUS (135)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
Which STANOZOLOL Alternatives Have Lower Left ventricular hypertrophy Risk?
STANOZOLOL vs STAVUDINE
STANOZOLOL vs STELARA
STANOZOLOL vs STIRIPENTOL
STANOZOLOL vs STIVARGA
STANOZOLOL vs STRATTERA